Outlook Therapeutics OTLK
NASDAQ OTLK
$0.57 -0.01 (-0.98%)
As of: Oct 1, 2026 · 3:30 PM EDT

Outlook Therapeutics (OTLK) Accounts Payables (2015 - 2026)

Updated

Outlook Therapeutics (OTLK) posted Accounts Payables of $6.81 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 33.7% from $10.26 million a year earlier and down 50.1% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Accounts Payables (2015 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Accounts Payables came in at $10.19 million, up 27.9% from FY2024.

  • Annual Accounts Payables has increased for four consecutive fiscal years, with a five-year compound annual growth rate of 33.6% (FY2020 to FY2025).
  • In prior fiscal years, Outlook Therapeutics' Accounts Payables was $7.97 million in FY2024 (+21.2%), $6.57 million in FY2023 (+88.3%), $3.49 million in FY2022 (+59.0%) and $2.2 million in FY2021 (-8.3%).
  • The fiscal Q3 2026 figure stands as the lowest quarterly Accounts Payables since fiscal Q3 2024.
  • On a year-over-year basis, Accounts Payables increased in six of the last eight quarters, with growth averaging 58.0%.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was fiscal Q1 2025, with growth of 250.3%; the weakest was fiscal Q1 2026, with a decline of 40.0%.
  • According to Business Quant data, Accounts Payables for the three prior fiscal quarters was $13.64 million (Q2 2026), $7.32 million (Q1 2026) and $10.19 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Outlook Therapeutics 77.94 Mn 42.19 Mn -8,265.00 6.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.81 Mn
Mar 31, 2026 13.64 Mn
Dec 31, 2025 7.32 Mn
Sep 30, 2025 10.19 Mn
Jun 30, 2025 10.26 Mn
Mar 31, 2025 7.77 Mn
Dec 31, 2024 12.19 Mn
Sep 30, 2024 7.97 Mn
Jun 30, 2024 5.55 Mn
Mar 31, 2024 4.36 Mn
Dec 31, 2023 3.48 Mn
Sep 30, 2023 6.57 Mn
Jun 30, 2023 5.06 Mn
Mar 31, 2023 3.62 Mn
Dec 31, 2022 4.17 Mn
Sep 30, 2022 3.49 Mn
Jun 30, 2022 2.48 Mn
Mar 31, 2022 4.16 Mn
Dec 31, 2021 2.55 Mn
Sep 30, 2021 2.20 Mn
API Access

Outlook Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=OTLK&period=max&api_key=YOUR_API_KEY